SCHEMBL6299378

SCHEMBL6299378

Cc1ccc(S(=O)(=O)C(O)CCCl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.42
ALDH1A1 P00352 8/20 0.40
CA2 P00918 3/20 0.40
MMP2 P08253 3/20 0.40
MMP9 P14780 3/20 0.40
CA1 P00915 2/20 0.40
MMP13 P45452 2/20 0.40
CYP2C9 P11712 2/20 0.40
MMP1 P03956 1/20 0.40
MMP8 P22894 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 1/20 0.40
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2780461 0.85 GAA (0.45) GAAALDH1A1CA2MMP2MMP9
SCHEMBL7584627 0.84 SMN1; SMN2 (0.44) GAAALDH1A1CA2MMP2MMP9
SCHEMBL4725679 0.84 CA2 (0.51) GAAALDH1A1CA2MMP2MMP9
SCHEMBL8473006 0.82 CA2 (0.44) GAAALDH1A1CA2MMP2MMP9
SCHEMBL2118076 0.81 GAA (0.45) GAAALDH1A1CA2MMP2MMP9
SCHEMBL4727639 0.81 CA2 (0.45) GAAALDH1A1CA2MMP2MMP9
SCHEMBL28292240 0.79 GAA (0.46) GAAALDH1A1CA2MMP2MMP9
SCHEMBL8778760 0.79 GAA (0.46) GAAALDH1A1CA2MMP2MMP9
SCHEMBL5799549 0.78 MCHR1 (0.48) GAAALDH1A1CA2MMP2MMP9
SCHEMBL15899120 0.78 MCHR1 (0.48) GAAALDH1A1CA2MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6942966-B1 libraries formed by permutations; combinatorial chemistry; drug screening ISIS PHARMACEUTICALS, INC. (US) 2005-09-13 US disclosed
US-6559303-B1 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical ISIS PHARMACEUTICALS, INC. 2003-05-06 US disclosed
US-6207826-B1 Macrocyclic compounds having nitrogen-containing linkages ISIS PHARMACEUTICALS, INC. 2001-03-27 US disclosed
US-6121433-A FOR DIAGNOSTIC, RESEARCH AND THERAPEUTIC USE; MIMIC OR MODULATE PROTEINS, ENZYMES, NUCLEIC ACIDS AND LIPIDS ISIS PHARMACEUTICALS, INC. (US) 2000-09-19 US disclosed
EP-0817787-A4 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2000-09-13 EP disclosed
US-6107482-A LARGE CYCLIC STRUCTURES INTERRUPTED BY AT LEAST ONE RING SYSTEM WHICH INCLUDES TWO BRIDGEHEAD ATOMS; CONTAIN PLURALITY NITROGENOUS SITES THAT ARE DERIVATIZED SUCH AS WITH DRUGS, NUCLEIC ACIDS, PROTEINS; USE IN LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 2000-08-22 US disclosed
EP-0746326-A4 OLIGOMERIC COMPOUNDS HAVING NITROGEN-CONTAINING LINKAGES ISIS PHARMACEUTICALS INC (US) 2000-06-14 EP disclosed
WO-1998010286-A1 METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS ISIS PHARMACEUTICALS, INC. (US) 1998-03-12 WO disclosed
EP-0817787-A1 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1998-01-14 EP disclosed
EP-0746326-A1 OLIGOMERIC COMPOUNDS HAVING NITROGEN-CONTAINING LINKAGES ISIS PHARMACEUTICALS, INC. (US) 1996-12-11 EP disclosed
WO-1996030377-A1 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1996-10-03 WO disclosed
WO-1995018623-A1 OLIGOMERIC COMPOUNDS HAVING NITROGEN-CONTAINING LINKAGES ISIS PHARMACEUTICALS, INC. (US) 1995-07-13 WO disclosed